Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

SHE:300436 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	119.51	143.95	202.83	238.98	393.57	135.99
Cash & Short-Term Investments	119.51	143.95	202.83	238.98	393.57	135.99
Cash Growth	-41.08%	-29.03%	-15.13%	-39.28%	189.41%	45.10%
Accounts Receivable	69.15	70.43	69.76	47.97	54.26	50.66
Other Receivables	1.34	28.83	25	8.21	4.94	2.02
Receivables	70.48	99.26	94.76	56.18	59.2	52.68
Inventory	121.13	114.48	111.48	68.66	81.8	52.71
Prepaid Expenses	-	-	-	-	-	0.01
Other Current Assets	66.92	49.61	40.22	30.48	15.32	16.15
Total Current Assets	378.05	407.3	449.29	394.3	549.89	257.54
Property, Plant & Equipment	574.53	588.4	639.49	584.83	509.63	420.78
Long-Term Investments	79.1	80.18	108.81	170.74	99.98	69.93
Goodwill	58.97	58.97	58.97	58.97	58.97	58.97
Other Intangible Assets	246.28	251.66	292.08	100.83	118.93	92.15
Long-Term Deferred Tax Assets	1.46	1.47	1.15	71.07	43.07	23.9
Long-Term Deferred Charges	36.07	42.78	47.75	55.22	32.56	63.96
Other Long-Term Assets	8.56	8.06	16.94	58.87	33.74	18.55
Total Assets	1,383	1,439	1,614	1,495	1,447	1,006
Accounts Payable	187.92	53.38	49.29	22.27	85.53	79.45
Accrued Expenses	5.77	174.67	175.34	89.05	38.62	37.76
Short-Term Debt	172.19	182.18	219.18	209.27	77.76	129.18
Current Portion of Long-Term Debt	134.2	117.92	72.12	17.94	62.47	-
Current Portion of Leases	-	0.1	0.18	0.19	0.11	-
Current Income Taxes Payable	6.63	2.91	1.67	3.8	3.77	3.01
Current Unearned Revenue	5.66	3.57	11.91	8.22	6.63	3.86
Other Current Liabilities	35.7	40.05	68.07	57.8	27.42	40.86
Total Current Liabilities	548.08	574.78	597.76	408.55	302.31	294.12
Long-Term Debt	139.71	142.36	167.69	84.04	47	82
Long-Term Leases	-	-	0.09	0.1	-	-
Long-Term Unearned Revenue	65.71	65.99	39.99	42.33	45.56	45.25
Long-Term Deferred Tax Liabilities	2.66	2.67	2.38	2.42	2.05	2.42
Other Long-Term Liabilities	259.6	256.24	237.31	1.79	-	-
Total Liabilities	1,016	1,042	1,045	539.22	396.92	423.79
Common Stock	159.27	159.27	159.27	159.27	158.78	140
Additional Paid-In Capital	607.93	607.93	607.93	671.32	659.29	176.43
Retained Earnings	-435.5	-407.01	-250.71	97.88	225.28	260.17
Total Common Equity	331.69	360.18	516.48	928.46	1,043	576.6
Minority Interest	35.56	36.6	52.76	27.16	6.49	5.39
Shareholders' Equity	367.25	396.78	569.24	955.62	1,050	581.99
Total Liabilities & Equity	1,383	1,439	1,614	1,495	1,447	1,006
Total Debt	446.1	442.56	459.27	311.55	187.33	211.18
Net Cash (Debt)	-326.6	-298.6	-256.44	-72.57	206.24	-75.19
Net Cash Per Share	-2.05	-1.87	-1.61	-0.46	1.38	-0.54
Filing Date Shares Outstanding	159.27	159.27	159.27	159.27	158.78	140
Total Common Shares Outstanding	159.27	159.27	159.27	159.27	158.78	140
Working Capital	-170.03	-167.48	-148.48	-14.25	247.58	-36.58
Book Value Per Share	2.08	2.26	3.24	5.83	6.57	4.12
Tangible Book Value	26.45	49.56	165.44	768.66	865.45	425.48
Tangible Book Value Per Share	0.17	0.31	1.04	4.83	5.45	3.04
Buildings	-	565.95	565.02	536.94	397.03	393.34
Machinery	-	267.27	268.43	179.92	116.23	108.6
Construction In Progress	-	29.76	29.86	50.6	147.22	44.15

Source: S&P Global Market Intelligence. Standard template. Financial Sources.